Growth Metrics

ENDRA Life Sciences (NDRA) Return on Assets (2017 - 2025)

ENDRA Life Sciences has reported Return on Assets over the past 5 years, most recently at 0.01% for Q4 2021.

  • Quarterly Return on Assets rose 1.0% to 0.01% in Q4 2021 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2021, up 1.0% year-over-year, with the annual reading at 0.01% for FY2021, 0.0% changed from the prior year.
  • Return on Assets was 0.01% for Q4 2021 at ENDRA Life Sciences, down from 0.01% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q3 2017 and troughed at 0.06% in Q1 2017.
  • The 5-year median for Return on Assets is 0.02% (2018), against an average of 0.02%.
  • The largest YoY upside for Return on Assets was 5bps in 2018 against a maximum downside of -4bps in 2018.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2017, then tumbled by -191bps to 0.02% in 2018, then fell by -7bps to 0.02% in 2019, then surged by 33bps to 0.02% in 2020, then skyrocketed by 52bps to 0.01% in 2021.
  • Per Business Quant, the three most recent readings for NDRA's Return on Assets are 0.01% (Q4 2021), 0.01% (Q3 2021), and 0.01% (Q2 2021).